REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N33 OOO (Аптека N33 ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N33 OOO Profile Updated: October 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Apteka N33 OOO (Аптека N33 ООО) is based in Russia, with the head office in Mikun. It operates in the Pharmacies and Drug Stores industry. The company was established on August 29, 2007. 1 (2023) employees currently work for Apteka N33 OOO (Аптека N33 ООО). From the latest financial highlights, Apteka N33 OOO (Аптека N33 ООО) reported a net sales revenue drop of 41.64% in 2025. A negative growth of 9.27% was recorded in its total assets. The net profit margin of Apteka N33 OOO (Аптека N33 ООО) increased by 23.21% in 2025.

Headquarters
Mechnikova, 12
Mikun; Komi Republic; Postal Code: 169060

Contact Details: Purchase the Apteka N33 OOO (Аптека N33 ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Apteka N33 OOO (Аптека N33 ООО) report to view the information.
Registered Capital:
Purchase the Apteka N33 OOO (Аптека N33 ООО) report to view the information.
Financial Auditors:
Purchase the Apteka N33 OOO (Аптека N33 ООО) report to view the information.
Incorporation Date:
August 29, 2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka N33 OOO (Аптека N33 ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-41.64%▼
Total Operating Revenue
-41.64%▼
Operating Profit
51.91%▲
Net Profit/Loss for the Period
51.91%▲
Total Assets
-9.27%▼
Total Equity
-9.27%▼
Operating Profit Margin
23.21%▲
Net Profit Margin
23.21%▲
Return on Equity (ROE)
8.21%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?